Tharimmune (THAR) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free THAR Stock Alerts $0.41 0.00 (0.00%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Tharimmune Short Interest DataCurrent Short Volume103,400 sharesPrevious Short Volume75,300 sharesChange Vs. Previous Month+37.32%Dollar Volume Sold Short$37,337.74Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares11,740,000 sharesFloat Size11,530,000 sharesShort Percent of Float0.90%Today's Trading Volume220,583 sharesAverage Trading Volume443,617 sharesToday's Volume Vs. Average50% Short Selling Tharimmune ? Sign up to receive the latest short interest report for Tharimmune and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTHAR Short Interest Over TimeTHAR Days to Cover Over TimeTHAR Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Tharimmune Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024103,400 shares $37,337.74 +37.3%0.9%0.2 $0.36 3/31/202475,300 shares $32,394.06 +230.3%0.7%0.1 $0.43 3/15/202422,800 shares $8,094.00 -69.9%0.2%0 $0.36 2/29/202475,700 shares $29,121.79 +44.2%0.7%0.1 $0.38 2/15/202452,500 shares $20,412.00 -75.7%0.5%0 $0.39 1/31/2024216,000 shares $95,040.00 No Change1.3%0.2 $0.44 THAR Short Interest - Frequently Asked Questions What is Tharimmune's current short interest? Short interest is the volume of Tharimmune shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 103,400 shares of THAR short. 0.90% of Tharimmune's shares are currently sold short. Learn More on Tharimmune's current short interest. What is a good short interest percentage for Tharimmune? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.90% of Tharimmune's floating shares are currently sold short. Is Tharimmune's short interest increasing or decreasing? Tharimmune saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 103,400 shares, an increase of 37.3% from the previous total of 75,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tharimmune's float size? Tharimmune currently has issued a total of 11,740,000 shares. Some of Tharimmune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tharimmune currently has a public float of 11,530,000 shares. How does Tharimmune's short interest compare to its competitors? 0.90% of Tharimmune's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tharimmune: Artelo Biosciences, Inc. (0.19%), NexImmune, Inc. (0.89%), Exicure, Inc. (2.01%), Petros Pharmaceuticals, Inc. (1.69%), Lipella Pharmaceuticals Inc. (1.49%), GT Biopharma, Inc. (0.27%), Longeveron Inc. (9.34%), Oragenics, Inc. (2.07%), Ensysce Biosciences, Inc. (0.14%), Genprex, Inc. (2.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tharimmune stock? Short selling THAR is an investing strategy that aims to generate trading profit from Tharimmune as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tharimmune? A short squeeze for Tharimmune occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of THAR, which in turn drives the price of the stock up even further. How often is Tharimmune's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THAR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Artelo Biosciences Short Squeeze NexImmune Short Squeeze Exicure Short Squeeze Petros Pharmaceuticals Short Squeeze Lipella Pharmaceuticals Short Squeeze GT Biopharma Short Squeeze Longeveron Short Squeeze Oragenics Short Squeeze Ensysce Biosciences Short Squeeze Genprex Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:THAR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable Prosperity[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport Society